149 related articles for article (PubMed ID: 31650)
1. Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions.
Persson SA
Psychopharmacology (Berl); 1978 Oct; 59(2):113-6. PubMed ID: 31650
[TBL] [Abstract][Full Text] [Related]
2. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
Persson SA
Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
[TBL] [Abstract][Full Text] [Related]
3. The effect of lysergic and diethylamide (LSD) and 2-bromolysergic acid diethylamide (BOL) on the striatal DOPA accumulation: influence of central 5-hydroxytryptaminergic pathways.
Persson SA; Johansson H
Brain Res; 1978 Mar; 142(3):505-13. PubMed ID: 25117
[TBL] [Abstract][Full Text] [Related]
4. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
5. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
[TBL] [Abstract][Full Text] [Related]
6. The effect of LSD and 2-bromo LSD on the DOPA accumulation after central and peripheral decarboxylase inhibition.
Hollunger G; Persson SA
Eur J Pharmacol; 1975 Mar; 31(1):156-8. PubMed ID: 1126375
[TBL] [Abstract][Full Text] [Related]
7. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
8. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
Peters DA; Tang S
J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
[No Abstract] [Full Text] [Related]
9. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
10. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
Larson AA; Chinn C; Proudfit HK; Anderson EG
J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
[TBL] [Abstract][Full Text] [Related]
11. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
Kehr W
Eur J Pharmacol; 1977 Feb; 41(3):261-73. PubMed ID: 837971
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
Andén NE; Corrodi H; Fuxe K; Hökfelt T
Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
[TBL] [Abstract][Full Text] [Related]
13. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.
Pettibone DJ; Pflueger AB
J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257
[TBL] [Abstract][Full Text] [Related]
14. Brain catecholamine content and turnover in aging rats.
Carfagna N; Trunzo F; Moretti A
Exp Gerontol; 1985; 20(5):265-9. PubMed ID: 4092759
[TBL] [Abstract][Full Text] [Related]
15. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King AR; Martin IL; Melville KA
Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
17. The effect of quipazine and LSD on monoamines in the rat striatum.
Miśkiewicz M; Rokosz-Pelc A; Vetulani J
Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
[TBL] [Abstract][Full Text] [Related]
18. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
[TBL] [Abstract][Full Text] [Related]
19. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
Gresch PJ; Strickland LV; Sanders-Bush E
Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
[TBL] [Abstract][Full Text] [Related]
20. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
Strömbom U
Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
